The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Concert Pharmaceuticals, Inc(NASDAQ:CNCE) 
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. Its lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmu...
Website: http://www.concertpharma.com
Founded: 2006
Full Time Employees: 71 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Concert Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Concert Pharmaceuticals Op Cashflow Per Share ttm
Concert Pharmaceuticals Free Cashflow Per Share ttm
Concert Pharmaceuticals Cash Per Share ttm
Concert Pharmaceuticals P/S ratio ttm
Concert Pharmaceuticals (GAAP) P/E ratio ttm
Concert Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.